Health Canada drug identification number

DIN 02559714 — LYNKUET 60 MG

LYNKUET is a capsule of Elinzanetant marketed by BAYER INC. The full Elinzanetant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02559714
Brand name
LYNKUET
Active ingredient
Elinzanetant
Strength
60 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
BAYER INC
Health Canada status
MARKETED
Drug class
Neurokinin-1,3 (NK-1,3) receptor antagonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.